(Q36409033)

14 August 2017

1 reference

title

Transactivating transcriptional activator-mediated drug delivery (English)

1 reference

14 August 2017

1 reference

Bhawna Gupta

1

1 reference

14 August 2017

Vladimir P Torchilin

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Expert Opinion on Drug Delivery

14 August 2017

published in

1 reference

14 August 2017

volume

3

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

177-190

1 reference

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cellular uptake of the tat protein from human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Intercellular trafficking and protein delivery by a herpesvirus structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Antennapedia homeobox peptide regulates neural morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cargo delivery kinetics of cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Arginine-mediated RNA recognition: the arginine fork.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Tat-mediated delivery of heterologous proteins into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Protein transduction: unrestricted delivery into all cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Possible existence of common internalization mechanisms among arginine-rich peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cell surface adherence and endocytosis of protein transduction domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

TAT peptide internalization: seeking the mechanism of entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

The caveolae membrane system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cationic TAT peptide transduction domain enters cells by macropinocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

VP22-mediated and light-activated delivery of an anti-c-raf1 antisense oligonucleotide improves its activity after intratumoral injection in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

TAT-mediated protein transduction into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

In vivo protein transduction: delivery of a biologically active protein into the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Tat-mediated protein delivery can facilitate MHC class I presentation of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Targeting proteins to mitochondria using TAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Transducible peptide therapy for uveal melanoma and retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Intracellular delivery of antibodies using TAT fusion protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Gene therapy. Side effects sideline hemophilia trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cationic liposome-mediated gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Gene delivery with synthetic (non viral) carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Design and gene delivery activity of modified polyethylenimines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: uptake and durability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

TAT conjugated, FITC doped silica nanoparticles for bioimaging applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Nanostructured materials designed for cell binding and transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Peptide-derivatized shell-cross-linked nanoparticles. 1. Synthesis and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Peptide-derivatized shell-cross-linked nanoparticles. 2. Biocompatibility evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Thiocholesterol-based lipids for ordered assembly of bioresponsive gene carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Intracellular targeting of polymer-bound drugs for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

Quantitation of the Tumor-Targeting Properties of Antibody Fragments Conjugated to Cell-Permeating HIV-1 TAT Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.177

21 January 2018

Identifiers

DOI

10.1517/17425247.3.2.177

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ord2kymsuvetdb2pou7qvkp2m4

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_ord2kymsuvetdb2pou7qvkp2m4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ord2kymsuvetdb2pou7qvkp2m4

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/ord2kymsuvetdb2pou7qvkp2m4

1 reference